β-D-Ribopyranoside, methyl O-β-D-xylopyranosyl-(1→4)-O-β-D-xylopyranosyl-(1→4)-2,3-anhydro-

4-Epi-L-vancosamine

Methyl-3-amino-2,3,6-tridesoxy-3-C-methyl-α-L-xylo-hexopyranosid

(3aR,6R,6aS)-6-Bromo-5-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxole

6-Amino-3,6-dideoxy-5-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-3-(methylamino)-D-myo-inositol

1-Amino-2-O-[(2S)-3α-amino-6-[(S)-1-aminoethyl]-3,4-dihydro-2H-pyran-2α-yl]-1,4-dideoxy-4-(methylamino)-D-scyllo-inositol

threitol

1-Amino-1,4-dideoxy-2-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-4-(methylamino)-D-scyllo-inositol

(3aR,6R,6aS)-6-Chloro-5-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxole

erythritol

4-O-benzoyl-L-oleandral (1,5-anhydro-4-O-benzoyl-2,6-dideoxy-3-O-methyl-L-arabino-hex-1-enitol)

Antibiotic A 201E (9CI)

Antibiotic A 201C (9CI)

D-myo-Inositol, 6-amino-5-O-(2-amino-2,3,4-trideoxy-α-D-erythro-hexopyranosyl)-3,6-dideoxy-2-O-methyl-3-(methylamino)- (9CI)

Fortimicin Ao

β-D-Glucopyranose, 1,6-anhydro-4-deoxy-4-(2-propen-1-yl)-, 2-(4-methylbenzenesulfonate)

4-[(Aminoacetyl)amino]-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-1-(methylamino)-L-chiro-inositol

Antibiotic TAI-A

1,2,5,6-tetra-O-acetyl-3,4-dideoxy-erythro-hexitol

3-O-demethylfortimicin A